Trials / Completed
CompletedNCT04597489
Fractional FLOw Reserve In Cardiovascular DiseAses
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 64,045 (actual)
- Sponsor
- LinkCare GmbH · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The FLORIDA (Fractional FLOw Reserve In cardiovascular DiseAses) study sought to investigate outcomes of FFR-guided versus angiography-guided treatment strategies in a large, real-world cohort.
Detailed description
The objective of the FLORIDA study was to investigate mortality outcomes of FFR-guided versus angiography-guided treatment strategies in a large, real-world patient cohort, including patients with different stages of coronary artery disease as well as patients with acute coronary syndrome (ACS). All patients were followed for a period of 3 years after the index date. The analysis period extended from the individual index date to the date of death or the end of the 3-year follow-up period. Patients were matched for sex, presence of acute coronary syndrome, age ± 5 years, and propensity scores estimated with logistic regression based on 72 variables , with each FFR patient matched to the closest angiography-only patient
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Fractional flow reserve | Patients were stratified into the FFR group if a coronary angiography with adjunctive FFR measurement was performed during the index hospitalization. |
| PROCEDURE | Angiography-only | Patients were stratified into the angiography-only group if a coronary angiography without adjunctive FFR measurement was performed. |
Timeline
- Start date
- 2019-12-01
- Primary completion
- 2020-01-20
- Completion
- 2020-03-02
- First posted
- 2020-10-22
- Last updated
- 2020-10-22
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04597489. Inclusion in this directory is not an endorsement.